Eye News and Research

Latest Eye News and Research

First study to focus on platelet genetics in African Americans

Researchers, led by scientists from Johns Hopkins, have found five previously unknown gene mutations believed to be associated with elevated blood platelet counts in African-Americans, findings they say could someday lead to the development of new drugs to help prevent coronary artery disease.

2 Mar 2012

Photon etc. announces the launch of IRIS, an innovative Retinal Hyperspectral Imaging system

Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tunable Laser Source, IRIS™ is a versatile instrument that allows high definition retinal imaging at any wavelength from 420 to 1000 nm. IRIS™ is the ideal research tool to better understand and develop tomorrow’s treatments for retinal diseases, such as diabetic retinopathy and age-related macular degeneration. This product is sold for research purposes only.

1 Mar 2012

First Edition: March 1, 2012

Today's headlines set the stage for the Senate's scheduled vote on a measure sponsored by Sen. Roy Blunt, R-Mo., that would allow employers and insurers to opt out of provisions in Obama's health care law to which they object on religious or moral grounds.

1 Mar 2012

Gluten-free, casein-free diet more effective in improving ASD behaviors and symptoms

A gluten-free, casein-free diet may lead to improvements in behavior and physiological symptoms in some children diagnosed with an autism spectrum disorder (ASD), according to researchers at Penn State. The research is the first to use survey data from parents to document the effectiveness of a gluten-free, casein-free diet on children with ASD.

1 Mar 2012

ACTB and ACTG1 actin genes cause Baraitser-Winter syndrome

Scientists from Seattle Children's Research Institute and the University of Washington, in collaboration with the Genomic Disorders Group Nijmegen in the Netherlands, have identified two new genes that cause Baraitser-Winter syndrome, a rare brain malformation that is characterized by droopy eyelids and intellectual disabilities.

1 Mar 2012

First study to show effects of ecstasy drug on fetal and infant development

A study led by Case Western Reserve University School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant development.

29 Feb 2012

Research compares basis for social dysfunction between ASD, schizophrenia

A UT Dallas professor is studying the differences between the social impairments found in autism and schizophrenia to help develop better treatments for people with both disorders.

29 Feb 2012

BrainAble project to offer benefits for people with motor disabilities

In the 2009 film Surrogates, humans live vicariously through robots while safely remaining in their own homes. That sci-fi future is still a long way off, but recent advances in technology, supported by EU funding, are bringing this technology a step closer to reality in order to give disabled people more autonomy and independence than ever before.

28 Feb 2012

Dompé enters definitive agreement to acquire Anabasis

Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.

28 Feb 2012

Largest study to date to observe dynamic social scenes in children with ASD

In a study published in the March 2012 issue of the Journal of the American Academy of Child and Adolescent Psychiatry, Katherine Rice and colleagues, from the Marcus Autism Center, Children's Healthcare of Atlanta, and Emory University School of Medicine, used eye-tracking technology to measure the relationship between cognitive and social disability in children with autism spectrum disorders (ASD) and the ability of children with ASD to pay attention to social interactions.

28 Feb 2012

OptiMedica launches Catalys Precision Laser System in the US

Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.

27 Feb 2012

Access to healthy food most problematic in low-income neighborhoods

Most convenience stores have a wide variety of chips, colorful candies and bottles of sugar-sweetened carbonated beverages. While shoppers can buy calorie-heavy foods wrapped in pretty packages in these locations, what they usually can't find are the fresh produce, whole grains and low-fat dairy products necessary for a healthy diet.

24 Feb 2012

Workshop increases pharmacy and medical students' empathy

One year ago, a landmark study led by Mohammadreza Hojat, Ph.D., research professor, Department of Psychiatry and Human Behavior at Thomas Jefferson University, quantified a relationship between physicians' empathy and their patients' positive clinical outcomes, suggesting that a physician's empathy is an important factor associated with clinical competence.

24 Feb 2012

First comprehensive framework to close the gap on Indigenous eye health for Australians

Presently Indigenous Australians suffer six times the blindness of mainstream Australians and 94 percent of vision loss in Indigenous Australians is unnecessary, preventable or treatable.

24 Feb 2012

Wolters Kluwer, APAO launch Asia-Pacific Journal of Ophthalmology

Wolters Kluwer Health and the Asia-Pacific Academy of Ophthalmology (APAO) are pleased to announce the launch of the Asia-Pacific Journal of Ophthalmology.

24 Feb 2012

Videotaped encounter evaluates medical students conveying bad news to 'standardized patients'

Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.

23 Feb 2012

AFA applauds nation's first National Alzheimer's Plan

The following is a statement by Eric J. Hall, president and CEO of the Alzheimer's Foundation of America (AFA), in response to the U.S. Department of Health and Human Services' release today of its "Draft National Plan To Address Alzheimer's Disease."

23 Feb 2012

State roundup: Calif. expands uninsured access, gives adult day care reprieve

Nearly two years before the federal health reform law kicks in, 10 California counties have expanded medical coverage to more than 250,000 people who were previously uninsured, according to new state data.

22 Feb 2012

FDA to review rejected weight loss drug Qnexa

The weight loss pill Qnexa has been once rejected by the FDA over safety concerns. But this Wednesday it will get a second chance before an FDA advisory committee. Qnexa maker Vivus Inc. hopes something might come out of this second chance. The company will be submitting new safety data from patients who took Qnexa for a second year after completing a one-year clinical trial.

21 Feb 2012

Quit-smoking drug Chantix effective in cocaine and alcohol addiction

Varenicline is unique among anti-addiction medications in the way it affects the brain. Like nicotine, varenicline activates a specific receptor for a neurotransmitter called acetylcholine, but it does so less intensely than the active ingredient of cigarettes does. The net effect is that the drug seems to help by both cutting cravings and making the formerly desired drug less pleasant — without making non-drug pleasures less intense. Alcohol works on the same chemical receptors in the brain as nicotine, and it may enhance the pleasurable effects of smoking.

18 Feb 2012